Puma Biotechnology | PBYI - Profitto Lordo Sulle Vendite





Profitto Lordo Sulle Vendite Cambiamento Data
Agios Pharmaceuticals USD 19.43M 1.34M 2026-03
Alnylam Pharmaceuticals USD 992.69M 167.68M 2026-06
Amgen USD 5.87B 1.02B 2026-03
Biogen USD 2.12B 307M 2026-06
BioMarin Pharmaceutical USD 713.42M 142.21M 2026-06
Daiichi Sankyo JPY 287.15B 152.68B 2026-03
Exelixis USD 608.03M 17.17M 2026-06
Gilead Sciences USD 6.8B 1.29B 2026-06
Glaxosmithkline GBP 5.75B 2.99B 2026-03
Incyte USD 1.57B 400.89M 2026-06
MacroGenics USD 11.24M 19.87M 2026-03
Moderna USD -566M 792M 2026-03
Novartis USD 11.24B 1.18B 2026-06
Pfizer USD -248M 11.29B 2026-06
PTC Therapeutics USD 232.94M 84.56M 2026-03
Puma Biotechnology USD 20.32M 24.85M 2024-09
Regeneron Pharmaceuticals USD 3.71B 778.2M 2026-06
Roche Holding CHF 22.69B 600M 2026-06
Sangamo BioSciences -2.39M 1.09M 2024-06
Sarepta Therapeutics USD 251.15M 370.2M 2026-06
Takeda JPY 813.22B 124.39B 2026-06
TG Therapeutics USD 199.14M 27.73M 2026-06
Ultragenyx Pharmaceutical USD 180M 74M 2026-06
Vanda Pharmaceuticals USD 50.6M 5.5M 2024-12
Vertex Pharmaceuticals USD 2.84B 242.4M 2026-06